Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer

Journal of Autoimmunity

Volumn 11, Issue 4, 1998, Pages 301-307

  Hong, Nguyen Mai ^a   Masuko Hongo, Kayo ^a   Sasakawa, Hiroko ^a   Kato, Tomohiro ^a   Shirai, Toshikazu ^b   Okumura, Ko ^b   Nishioka, Kusuki ^a   Kobata, Tetsuji ^a,b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Fas Fas ligand interaction; Gene therapy; Gld; Hypergammaglobulinemia; Lymphoid hyperplasia

Indexed keywords

FAS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INTERACTION; GENE TARGETING; GENE THERAPY; HYPERGAMMAGLOBULINEMIA; LUPUS ERYTHEMATOSUS; LYMPHOID HYPERPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0344333433     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0204     Document Type: Article

References (19)

1. Cohen P.L., Eisenberg R.A. 1991. Ipr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269
2. Cohen P.L., Eisenberg R.A. 1992. The Lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today 13: 427-428
3. Watanabe-Fukunaga R., Brannan C.I., Copland N.G., Jenkins N.A., Nagata S. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317
4. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., Nagata S. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976
5. Lynch D.H., Watson M.L., Alderson M.R., Baum P.R., Miller R.E., Tough T.W., Gibson M., Davis-Smith T., Smith C.A., Hunter K., Bhat D., Dinr W., Goodwin R.G., Seldin M.F. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136
6. Allen R.D., Marshall J.D., Roths J.B., Sidman C.L. 1990. Different defined by bone marrow transplantation suggest hat lpr and gld are mutation of genes encoding an interacting pair of molecules. J. Exp. Med. 172: 1367-1375
7. Sobel E.S., Kakkanaiah V.N., Cohen P.L., Eisenberg R.A. 1993. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene. Int. immunol. 5: 1275-1278
8. Nagata S., Suda T. 1995. Fas and Fas ligand: lpr and gld mutation. Immunol. Today 16: 39-43
9. Lynch D.H., Ramsdell F., Alderson M.R. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16: 569-574
10. Kobata T., Takasaki K., Asahara H., Hong N.M., Masuko-Hongo K., Kato T., Hirose S., Shirai T., Kayagaki N., Yagita H., Okumura K., Nishioka K. 1997. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice. Immunology 92: 206-213
11. Seino K., Kayagaki N., Bashuda H., Okumura K., Yagita H. 1996. Contribution of Fas ligand to cardiac allograft rejection. Int. Immunol. 8: 1347-1354
12. Kayagaki N., Yamaguchi N., Nagao F., Matsuo S., Maeda H., Okumura K., Yagita H. 1997. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94: 3914-3919
13. Gavrich Y., Sherman Y., Ben-Sasson S.A. 1992 Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119: 493-498
14. Karasuyama H., Tohyama N., Tada T. 1989. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J. Exp. Med. 169: 13-25
15. Fujisawa K., Asahara H., Okamoto K., Aono H., Hasunuma T., Kobata T., Iwakura Y., Yonehara S., Sumida T., Nishioka K. 1996. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J. Clin. Invest. 98: 271-278
16. Okamoto K., Asahara H., Kobayashi T., Matsuno H., Hasunuma T., Kobata T., Sumida T., Nishioka K. 1998. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Therapy 5: 331-338
17. Zhang H., Yang Y., Horton J.L., Samoilova E.B., Judge T.A., Turka L.A., Wilson J.M., Chen Y. 1997. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J. Clin. Invest. 100: 1951-1957
18. Nishimura-Morita Y., Nose M., Inoue T., Yonehara S. 1997. Amelioration of systemic autoimmune disease by the stimulation of apoptosis-promoting receptor Fas with anti-Fas mAb. Int. Immunol. 9: 1793-1799
19. Wu J., Wilson J., He J., Xiang L., Schur P.H., Mountz J.D. 1996. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin Invest. 98: 1107-1113